Response to influenza virus vaccination in vertical HIV infection

Archives of Disease in Childhood

Volumn 76, Issue 3, 1997, Pages 215-218

  Lyall, E G H ^a,c   Charlett, A ^b   Watkins, P ^a   Zambon, M ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

influenza vaccination; paediatric HIV infection

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; INFLUENZA VACCINATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030963516     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.76.3.215     Document Type: Article

References (15)

1. McIntosh K. In: Pizzo PA, Wilfert CM, eds. Paediatric AIDS, the challenge of HIV infection in infants, children, and adolescents. 2nd Ed. Baltimore: Williams and Wilkins, 1993:365-76.
2. Kempe A, Hall CB, MacDonald NE, et al. Influenza in children with cancer. J Pediatr 1989;115:33-9.
3. Mauch TJ, Bratton S, Myers T, Krane E, Gentry SR, Kashtan CE. Influenza B virus infection in paediatric solid organ transplant recipients. Pediatrics 1994;94:225-9.
4. Advisory Committee on Immunisation Practices (ACIP) of the US Public Health Service. Prevention and Control of Influenza: part 1, Vaccines. MMWR 1994:275-83.
5. Department of Health. Immunisation against infectious disease. London: HMSO, 1992:96.
6. Hall CB. Influenza - a shot or not? Pediatrics 1987;79:564-5.
7. Zuckerman MA, Wood J, Chakraverty P, Taylor J, Heath AB, Oxford JS. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine:antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response. J Med Virol 1991;33:133-7.
8. Bernstein DI, Cherry JD. Clinical reactions and antibody responses to influenza vaccines. Am J Dis Child 1983;137: 622-6.
9. Gruber WC, Taber LH, Glezen P, et al. Live attenuated and Inactivated Influenza vaccine in school-age children. Am J Dis Child 1990;144:595-600.
10. Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunisationof high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991;87:823-8.
11. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991;163:300-4.
12. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994;43:Sept 30, No RR -12.
13. Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, Edwards KM. Serologic response to standard inactivated influenza vaccine in HIV-infected children. Pediatr Infect Dis J 1994;143:206-11.
14. O'Brien WA, Grovit-Ferbas K, Namazi A, et al. HIV-type1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
15. Yerli S, Wunderli W, Wyler CA, et al. Influenza immunisation of HIV-1 infected patients does not increase HIV-1 viral load. AIDS 1994;8:1503-4.